newsfilter
← Latest News
GlobeNewswire·

Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update

Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programsCash position expected to fund operations into second quarter of 2025Two Phase 1